These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 25218681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
    Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.
    Eur J Clin Invest; 2015 Apr; 45(4):394-404. PubMed ID: 25682967
    [Abstract] [Full Text] [Related]

  • 3. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
    Zhang C, Liang S, Cheng S, Li W, Wang X, Zheng C, Zeng C, Shi S, Xie L, Zen K, Liu Z.
    J Transl Med; 2018 Apr 10; 16(1):91. PubMed ID: 29636065
    [Abstract] [Full Text] [Related]

  • 4. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis.
    Xiao B, Wang LN, Li W, Gong L, Yu T, Zuo QF, Zhao HW, Zou QM.
    Cell Death Dis; 2018 May 01; 9(5):533. PubMed ID: 29748623
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 01; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 6. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
    Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z.
    Nephrology (Carlton); 2012 May 01; 17(4):338-45. PubMed ID: 22295953
    [Abstract] [Full Text] [Related]

  • 7. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A, Dial C, Ka EF, Lèye A, Pouye A, Ka MM, Mbengue M, Droz D, Diouf B.
    Dakar Med; 2008 May 01; 53(1):45-51. PubMed ID: 19102117
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
    Segarra A, Jatem E, Quiles MT, Arbós MA, Ostos H, Valtierra N, Carnicer C, Salcedo MT.
    Nefrologia; 2014 May 01; 34(1):53-61. PubMed ID: 24463863
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Higher Urine Exosomal miR-193a Is Associated With a Higher Probability of Primary Focal Segmental Glomerulosclerosis and an Increased Risk of Poor Prognosis Among Children With Nephrotic Syndrome.
    Wang L, Wang J, Wang Z, Zhou J, Zhang Y.
    Front Cell Dev Biol; 2021 May 01; 9():727370. PubMed ID: 34708038
    [Abstract] [Full Text] [Related]

  • 13. Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors.
    Zhang Q, Zeng C, Cheng Z, Xie K, Zhang J, Liu Z.
    J Nephrol; 2012 May 01; 25(5):679-88. PubMed ID: 22009935
    [Abstract] [Full Text] [Related]

  • 14. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM.
    Rev Assoc Med Bras (1992); 2024 May 01; 70(4):e20230871. PubMed ID: 38716932
    [Abstract] [Full Text] [Related]

  • 15. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    McCarthy ET, Sharma M, Savin VJ.
    Clin J Am Soc Nephrol; 2010 Nov 01; 5(11):2115-21. PubMed ID: 20966123
    [Abstract] [Full Text] [Related]

  • 16. Depletion of clusterin in renal diseases causing nephrotic syndrome.
    Ghiggeri GM, Bruschi M, Candiano G, Rastaldi MP, Scolari F, Passerini P, Musante L, Pertica N, Caridi G, Ferrario F, Perfumo F, Ponticelli C.
    Kidney Int; 2002 Dec 01; 62(6):2184-94. PubMed ID: 12427144
    [Abstract] [Full Text] [Related]

  • 17. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
    Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, Koziell A, Zaritsky JJ.
    Pediatr Nephrol; 2019 Nov 01; 34(11):2343-2350. PubMed ID: 31250206
    [Abstract] [Full Text] [Related]

  • 18. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
    Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, Snanoudj R, Charbit M, Salomon R, Martinez F, Legendre C, Noel LH, Niaudet P.
    Nephrol Dial Transplant; 2010 Apr 01; 25(4):1321-8. PubMed ID: 19773419
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A.
    BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.